Technology | Breast Imaging | January 25, 2017

HealthDecision LLC Launches Personalized Breast Cancer Screening Software Tool

Software embedded within electronic health records looks at patient’s healthcare data and history to calculate individual risk for developing breast cancer in the next decade

HealthDecision, Breast Cancer Screening tool, personalized risk, UW Health, launch

January 25, 2017 — HealthDecision LLC recently announced the launch of the Breast Cancer Screening tool. This tool provides patients a personalized risk analysis for developing breast cancer in the next 10 years and the benefits or harms associated with mammogram screening.

The tool was tested and currently is used within University of Wisconsin (UW) Health, a healthcare system in the upper Midwest serving 600,000 patients each year with 1,400 physicians and 16,500 staff at six hospitals and 80 outpatient sites.

The Breast Cancer Screening tool is the result of a 2013 WI Partnership Program grant received by the UW Madison Department of Radiology and a joint effort with HealthDecision LLC to create a shared decision-making (SDM) tool that could be used at a routine appointment within a doctor's office. The project grew out of the controversy and confusion about breast cancer screening, and its multidisciplinary team included members from surgery, engineering, psychology, communications, primary care, vascular surgery research and decision making.

HealthDecision is unique in that it is embedded within the electronic health record (EHR) system and considers the patient's healthcare data and history to calculate personalized risk. Risks associated with mammogram screening include over-detection and the subsequent effects of anxiety; possible overtreatment with surgery, radiotherapy and sometimes chemotherapy; cost; and additional impacts on quality of life.

"Healthcare guidelines can be confusing to patients as well as doctors, especially when there is conflicting information in the public domain," said Sarina Schrager, M.D., UW Health and professor in the University of Wisconsin Department of Family Medicine and Community Health. Along with Beth Burnside, M.D., UW Health, who was the principle investigator on the grant, Schrager was heavily involved in the development of the tool, educating other primary care clinicians and driving the implementation strategy within UW Health primary care. "HealthDecision aids my conversation with the patient to better educate and explain the harms and benefits of a mammogram and its possible outcomes. The visualized risk analysis has been key for patients to better understand their personalized risk and increases their confidence to make better informed healthcare decisions for themselves."

The Breast Cancer Screening tool joins a suite of three other HealthDecision shared decision-making tools that provide a patient's personalized risk for the various healthcare options available:

  • The Atrial Fibrillation tool demonstrates a patient's risk of stroke or bleeding from anticoagulant medications;
  • The Cardiovascular Risk tool evaluates a patient's cholesterol and their risk of various statin medications and smoking cessation; and
  • The Lung Cancer Screening tool considers the risk for chest computed tomography (CT) scans for patients who smoke or have smoked.

For more information: www.healthdecision.org

Related Content

digital mammography trends, improved cancer detection, more biopsies, Radiology journal, BCSC study, Breast Cancer Surveillance Consortium
News | Mammography | February 23, 2017
The shift from film to digital technology appears to have improved cancer detection rates for diagnostic mammography,...
digital breast tomosynthesis, DBT, synthesized 2-D mammography, S2D, screening recall rates, Radiology journal study
News | Mammography | February 22, 2017
A new digital breast tomosynthesis technique has the potential to reduce the rate at which women are called back for...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
fibroglandular breast density, breast cancer screening performance, Breast Cancer Research and Treatment study, Volpara Density
News | Breast Density | February 17, 2017
In the first large-scale study of its kind, Dutch researchers demonstrated a strong linear relationship between...
deep learning, artificial inteligence, medical imaging, Signify Research market report, 2021
News | Artificial Intelligence | February 15, 2017
February 15, 2017 — Deep learning, also known as ...
TMIST, lead-in study, tomosynthesis, mammography, The Ottawa Hospital Breast Health Centre, Canada
News | Breast Imaging | February 15, 2017
Researchers from The Ottawa Hospital Breast Health Centre and the Ottawa Integrative Cancer Centre (OICC) have opened...
FDA, MQSA, mammography record retention and transfer
Feature | Mammography | February 13, 2017
The U.S. Food and Drug Administration (FDA) has released a new document detailing best practices for retaining patient...
Rapid Breast MRI, breast cancer screening, David Strahle, RMI, Breast Cancer Research and Treatment study
News | MRI Breast | February 10, 2017
February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives
dense breast tissue, contralateral breast cancer, MD Anderson study, Cancer journal
News | Women's Health | February 09, 2017
February 9, 2017 — Breast cancer patients with...
screening mammograms, false positive, true negative, screening behavior, Firas M. Dabbous, Cancer Epidemiology Biomarkers & Prevention
News | Mammography | February 09, 2017
A new study published in Cancer Epidemiology: Biomarkers & Prevention found that women who had a false positive...
Overlay Init